4.6 Review

Hydrogen Sulfide (H2S): As a Potent Modulator and Therapeutic Prodrug in Cancer

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 30, Issue 40, Pages 4506-4532

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867330666230126100638

Keywords

Hydrogen sulfide; anti-tumor; pro-cancer; cancer biomarker; hydrogen sulfide donor and preclinical trials; therapeutic prodrug

Ask authors/readers for more resources

Hydrogen sulfide (H2S) is an endogenous gaseous molecule studied for its toxicity, but recent research has shown its relevance as a signaling molecule with potential implications in clinical disorders and cancer. This article provides an overview of H2S's properties, enzymatic pathways, and role as a signaling molecule. It also discusses the potential of H2S-releasing agents as therapeutic tools, the paradoxical role of H2S in tumor biology, and the use of H2S levels as cancer biomarkers. Additionally, it describes the preclinical applications of H2S-releasing compounds in assessing their anti-cancer impact.
Hydrogen sulfide (H2S) is an endogenous gaseous molecule present in all living organisms that has been traditionally studied for its toxicity. Interestingly, increased understanding of H2S effects in organ physiology has recently shown its relevance as a signalling molecule, with potentially important implications in variety of clinical disorders, including cancer. H2S is primarily produced in mammalian cells under various enzymatic pathways are target of intense research biological mechanisms, and therapeutic effects of H2S. Herein, we describe the physiological and biochemical properties of H2S, the enzymatic pathways leading to its endogenous production and its catabolic routes. In addition, we discuss the role of currently known H2S-releasing agents, or H2S donors, including their potential as therapeutic tools. Then we illustrate the mechanisms known to support the pleiotropic effects of H2S, with a particular focus on persulfhydration, which plays a key role in H2S-mediating signalling pathways. We then address the paradoxical role played by H2S in tumour biology and discuss the potential of exploiting H2S levels as novel cancer biomarkers and diagnostic tools. Finally, we describe the most recent preclinical applications focused on assessing the anti-cancer impact of most common H2S-releasing compounds. While the evidence in favour of H2S as an alternative cancer therapy in the field of translational medicine is yet to be clearly provided, application of H2S is emerging as a potent anticancer therapy in preclinical trails.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available